Company Overview of Amorcyte, LLC
Amorcyte, LLC develops cell therapy products for the treatment of cardiovascular diseases. Its product includes AMR-001, a bone marrow-derived, CD34 positive selected stem cell product for the prevention of major adverse cardiac events following acute myocardial infarction. The company was incorporated in 2005 and is based in Allendale, New Jersey. As of October 17, 2011, Amorcyte, LLC operates as a subsidiary of Neostem, Inc.
4 Pearl Court
Allendale, NJ 07401
Founded in 2005
Key Executives for Amorcyte, LLC
Similar Private Companies By Industry
|Cytoprint Inc.||United States|
|Vector Medical Technologies, Inc.||United States|
|ProFibrix, Inc.||United States|
|Chantal Pharmaceutical||United States|
|Kytogenics Pharmaceutical, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Amorcyte, LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.